• Proposed T-Mobile, Sprint Merger Passes Two Key Security Reviews
    The Committee on Foreign Investment in the United States and "Team Telecom" (made up of reps from various government departments) both approved the merger.
  • J&J Hits Back Hard After Reuters Report Charges Talc Cover-Up
    Despite its denials, Johnson & Johnson's stock continues to take a pummeling in pre-market trading this morning.
  • Starbucks Rolling Out Delivery In 2,000 Of Its U.S. Stores
    The coffee chain is expanding a Uber Eats pilot program to seven unnamed U.S. metropolitan areas in the coming months.
  • Looking To Expand Its Multicultural Business, P&G Buys Walker & Co.
    Walker & Co. is best known for Bevel, a shaving system designed specifically for men of color, and the more-recent FORM Beauty, targeted to African-American women.
  • McDonald's Flexes Muscles Announcing Reduction Of Antibiotics In Beef
    Company says move is "industry-leading commitment" to help preserve "effectiveness of antibiotics for human and animal health in the future."
  • Arrest Of Huawei CFO Could Have Long-Term Repercussions For Tech
    Fallout should be "at the very least, an even more difficult relationship for the handful of U.S. tech giants that have found great fortune in China," says one report.
  • Kraninger Will Run CFPB Despite Lack Of Consumer Finance Experience
    "Republicans argued that her management experience at the OMB qualified her for the job," while "Democrats disagreed," according to one report.
  • MoviePass Launches New Pricing Scheme With PR Blitz
    The three-tiered subscription plan is also priced more expensively in markets like New York and L.A. than it is in the heartland.
  • Kroger Setting Up Shops Within 13 Walgreens, Launches Meal Kits Offering
    Partnership between largest U.S. largest supermarket retailer and biggest drug chain "aims to promote a convenient, one-stop shopping experience."
  • GlaxoSmithKline Buys U.S. Cancer Drug After Selling Horlicks To Unilever
    The pharma company bought Tesaro, a biopharma best known for Zejula, a developing treatment that uses the body's immune system to battle ovarian cancer.
« Previous Entries